These results suggest that UHRF1 has a regulatory role in adipogenesis, fibrosis, and inflammation, which may have therapeutic value in treating obesity and its related comorbidities. This evidence concerns the gene UHRF1 and obesity due to melanocortin 4 receptor deficiency.